BALAXI PHARMACEUTICALS per share figures

·UnclassifiedChart ›

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

₹0.45	₹0.26	₹4.54	−₹2.32	₹45.81	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹0.45	₹0.26	₹4.54	−₹2.31	₹45.40
₹45.12	₹45.12	₹41.98	₹184.78	₹179.62
₹50.74	₹48.94	₹52.99	₹221.42	₹330.44
—	−₹0.82	−₹6.34	₹4.47	₹5.97
−₹3.51	−₹3.51	−₹6.59	₹3.83	−₹4.64
—	₹0.00	₹0.00	₹0.00	₹0.49
5.5	5.5	5.5	1.1	1.0

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

BALAXI₹19.71

BALAXI PHARMACEUTICALS LIMITED

· Unclassified

₹ CrorePeersPAR STEELCITY LATTEYS CROWN HECPROJECT HINDCON AIROLAM GROBTEAMcap ₹109 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

₹ per share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Basic EPS	45.81	-2.32	4.54	0.26	0.45
Diluted EPS	45.40	-2.31	4.54	0.26	0.45
Book Value per Share	179.62	184.78	41.98	45.12	45.12
Revenue per Share	330.44	221.42	52.99	48.94	50.74
Cash Flow per Share	5.97	4.47	-6.34	-0.82	—
Free Cash Flow per Share	-4.64	3.83	-6.59	-3.51	-3.51
Dividends per Share	0.49	0.00	0.00	0.00	—
Shares Outstanding (cr)	1.0	1.1	5.5	5.5	5.5

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.